Leadership Overview
USV Private has 8 executives leading key functions including financial strategy, information technology, operational management, human resources, sales, marketing, and biologics development.
Focused on advancing global health through pharmaceutical innovation, USV Private maintains a commitment to high-quality biotechnology solutions while expanding market reach across international territories.
Focused on advancing global health through pharmaceutical innovation, USV Private maintains a commitment to high-quality biotechnology solutions while expanding market reach across international territories.
Leadership Roles at USV Private
Jogendra Sethi - Chief Financial Officer
Jogendra Sethi, the Chief Financial Officer at USV Private, directs all fiscal planning and capital allocation strategies for the organization. Managing the financial health of this multinational pharmaceutical entity, the Chief Financial Officer oversees complex budgeting processes and long-term investment portfolios. By analyzing market trends within the biotechnology sector, Sethi ensures the company maintains robust liquidity to support ongoing research and development initiatives. The Chief Financial Officer collaborates with the board to optimize cost structures and drive sustainable revenue growth across global markets. Through rigorous financial oversight, Jogendra Sethi mitigates operational risks while maximizing shareholder value. This leadership role requires constant monitoring of international regulatory environments to ensure compliance with diverse fiscal standards. Ultimately, Sethi secures the necessary capital to fuel the expansion of pharmaceutical manufacturing capabilities, ensuring the company remains competitive in a rapidly evolving global healthcare landscape.
Jayant Dwivedy - Executive Director & Chief Operating Officer
Jayant Dwivedy, the Executive Director & Chief Operating Officer at USV Private, manages the daily production cycles and manufacturing excellence across all pharmaceutical facilities. Overseeing the entire supply chain, the Executive Director & Chief Operating Officer ensures that high-quality biotechnology products reach global markets with maximum efficiency. Dwivedy coordinates with production managers to streamline manufacturing processes, reducing waste while maintaining strict adherence to international quality standards. By optimizing operational workflows, the Executive Director & Chief Operating Officer supports the company's mission to deliver reliable healthcare solutions. Jayant Dwivedy monitors performance metrics to identify bottlenecks and implements corrective strategies to enhance output capacity. This leadership position requires deep engagement with regulatory bodies to ensure all manufacturing operations meet safety and efficacy requirements. Through disciplined operational management, Dwivedy drives the company's ability to scale production in response to increasing global demand for pharmaceutical products.

Rohit Chro - President & Chief Human Resources Officer
Rohit Chro, the President & Chief Human Resources Officer at USV Private, leads the strategic integration of corporate culture with executive leadership initiatives. Overseeing the alignment of human capital with the company's long-term vision, the President & Chief Human Resources Officer drives organizational change to support growth in the pharmaceutical sector. Chro manages executive development programs and leadership pipelines to ensure the company possesses the necessary expertise to navigate complex market challenges. By championing employee engagement and wellness initiatives, the President & Chief Human Resources Officer enhances productivity across all global operations. Rohit Chro works closely with the board to define the company's values and ensure these principles guide all business decisions. This role requires a focus on building a resilient organization capable of adapting to rapid shifts in the biotechnology landscape. Through visionary leadership, Chro strengthens the company's internal foundation, enabling sustained success and innovation in the competitive healthcare industry.
Singh Yogender - President (Sales & Marketing)
Singh Yogender, the President (Sales & Marketing) at USV Private, directs the commercial strategy and market expansion efforts for the company's pharmaceutical portfolio. Overseeing the development of regional sales networks, the President (Sales & Marketing) drives revenue growth by identifying new market opportunities and strengthening relationships with healthcare providers. Yogender manages the marketing campaigns that promote the company's biotechnology products to diverse audiences across international territories. By analyzing competitive positioning, the President (Sales & Marketing) ensures that the company's offerings remain at the forefront of the industry. Singh Yogender coordinates with the product development teams to align sales messaging with the unique benefits of new pharmaceutical innovations. This role involves managing large-scale distribution channels to ensure consistent product availability. Through aggressive market penetration and strategic brand management, Yogender secures the company's position as a leader in the global pharmaceutical and biotechnology landscape.
Esmail Samiwala - President, Biologics
Esmail Samiwala, the President, Biologics at USV Private, leads the research, development, and commercialization of the company's biologics division. Overseeing the specialized teams focused on complex biotechnology, the President, Biologics drives the innovation pipeline to create advanced therapeutic solutions. Samiwala manages the clinical trial processes and regulatory submissions required to bring new biologic products to market. By fostering partnerships with research institutions, the President, Biologics accelerates the discovery of novel treatments for chronic diseases. Esmail Samiwala ensures that all development activities adhere to the highest standards of scientific rigor and safety. This role involves coordinating with manufacturing leaders to transition successful research projects into large-scale production. Through deep technical expertise and strategic oversight, Samiwala positions the company as a key player in the biologics sector, delivering high-impact medical solutions that address unmet patient needs across global healthcare markets.

Anuj Maheshwari - President
Anuj Maheshwari, the President at USV Private, directs the overall corporate strategy and operational execution for the entire organization. Overseeing the alignment of all business units, the President ensures that the company's pharmaceutical and biotechnology objectives remain consistent with the long-term mission. Maheshwari manages the executive team to drive growth, efficiency, and innovation across all global operations. By evaluating market trends and economic conditions, the President identifies strategic opportunities for expansion and diversification. Anuj Maheshwari represents the company in high-level negotiations and maintains relationships with key stakeholders, including investors and regulatory authorities. This leadership role requires a comprehensive understanding of the pharmaceutical industry's complexities and a commitment to delivering high-quality healthcare solutions. Through decisive leadership and a focus on operational excellence, Maheshwari guides the company toward sustained success, ensuring that the organization continues to make a significant impact on global health outcomes.
Govind Joshi - Chief Information Officer
Govind Joshi, the Chief Information Officer at USV Private, architects the digital infrastructure supporting pharmaceutical manufacturing and biotechnology research. Overseeing the integration of advanced data analytics, the Chief Information Officer drives the modernization of internal systems to improve operational efficiency. Joshi manages the cybersecurity framework protecting sensitive research data and intellectual property across all regional operations. By implementing scalable cloud solutions, the Chief Information Officer enables seamless collaboration between global research teams and manufacturing facilities. Govind Joshi prioritizes the adoption of emerging technologies to accelerate drug discovery timelines and optimize supply chain visibility. This role involves constant coordination with other executive leaders to align technological investments with the broader corporate mission. Through strategic digital transformation, Joshi ensures the company maintains a technological edge in the competitive pharmaceutical industry, fostering innovation and data-driven decision-making across every department.
Aparna Vishwasrao - Chief Human Resources Officer
Aparna Vishwasrao, the Chief Human Resources Officer at USV Private, directs talent acquisition and organizational development strategies to support the company's workforce. Overseeing the cultivation of a high-performance culture, the Chief Human Resources Officer implements training programs that align employee skills with the evolving needs of the biotechnology sector. Vishwasrao manages compensation structures and performance management systems to attract and retain top-tier scientific and operational talent. By fostering an inclusive work environment, the Chief Human Resources Officer ensures that the company maintains a diverse and motivated team capable of driving pharmaceutical innovation. Aparna Vishwasrao collaborates with department heads to address workforce planning and succession strategies, ensuring long-term organizational stability. This role involves navigating complex labor regulations across various regions to maintain compliance and employee satisfaction. Through strategic human capital management, Vishwasrao empowers the workforce to achieve the company's ambitious goals in the global healthcare market.
Explore Leadership Teams in Manufacturing
AbbVie Inc. is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines and health solutions that address some of the worlds most complex medical challenges. Headquartered in North Chicago, Illinois, the company operates internationally and focuses on advancing treatments that improve patient outcomes and overall quality of life. AbbVies scientific and commercial efforts are concentrated in several core therapeutic areas, including immunology, oncology, neuroscience, eye care, and medical aesthetics, along with other specialty areas where significant unmet medical needs exist. Through these focus areas, the company works to create therapies that help patients manage chronic, serious, and often life-altering diseases.
Company Leadership PP
MH
Eisai is a global pharmaceutical manufacturing company founded in 1941. The company develops and produces medicines while focusing on a human health care approach that extends beyond traditional pharmaceutical services. Eisai operates across multiple regions including North America, Europe, Asia Pacific, and the Middle East, with a strong presence in countries such as the United States, Japan, China, and the United Kingdom. The company maintains a significant focus on research and development in the pharmaceutical sector, with particular emphasis on patient-centered healthcare solutions. Eisai's business model encompasses both business-to-business and business-to-consumer operations, reflecting its comprehensive approach to healthcare delivery and pharmaceutical development.
Company Leadership
MM


Abdi Ibrahim provides pharmaceutical services to the healthcare sector that are beneficial in maintaining people's health. Abdi Ibrahim was founded in 1912 and is based in Istanbul, Turkey.
Company Leadership AO
MÇ
21st Century Vitamins operates as a globally recognized manufacturer and distributor of dietary supplements, positioned within the broader health and wellness industry. The company, through its parent entity 21st Century HealthCare, Inc., focuses on developing, producing, and delivering a wide range of vitamins, minerals, herbal supplements, and specialty nutritional products designed to support everyday health and well-being. With a history spanning more than three decades, the organization has established itself as a trusted and accessible brand in the consumer healthcare market. At its core, the company functions as both a manufacturer and a direct-to-consumer wellness provider. It produces an extensive portfolio of dietary supplements that cater to diverse health needs, including general nutrition, immune support, cardiovascular health, digestive wellness, sports nutrition, and beauty supplements. Its offerings range from traditional multivitamins and single-nutrient formulations to advanced blends such as amino acids, probiotics, and plant-based supplements. This breadth of product categories reflects the companys strategy of addressing a wide spectrum of consumer health requirements through scientifically formulated solutions.
Company Leadership SS
KW
FC